Cellino Biotech, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of advanced cell therapies. The organization focuses on harnessing the power of automation and artificial intelligence to enhance the production and quality of cell-based treatments. By integrating cutting-edge technologies, Cellino aims to streamline the manufacturing processes of personalized medicine, addressing critical challenges in the field of regenerative medicine and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#231 in Cambridge, MA

#1,773 in Massachusetts

#29,882 in US

#56,092 in the World

Cambridge, MA, United States of America

Cellino Biotech, Inc.

Forward Citations = 17

21 inventors:

Matthias Wagner (10 out of 49 patents)

Catherine Pilsmaker (9 out of 9 patents)

Suvi Aivio (9 out of 9 patents)

4. Ozge Whiting (8 out of 10 patents)

5. Steven Nagle (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellino Biotech, Inc.. Retrieved from https://idiyas.com/company/cellino-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]